BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 1358383)

  • 41. Selectivity of benzodioxane alpha-adrenoceptor antagonists for alpha 1- and alpha 2-adrenoceptors determined by binding affinity.
    Timmermans PB; van Kemenade JE; Batink HD; van Zwieten PA
    Pharmacology; 1983; 26(5):258-69. PubMed ID: 6134295
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Failure of AH11110A to functionally discriminate between alpha(1)-adrenoceptor subtypes A, B and D or between alpha(1)- and alpha(2)-adrenoceptors.
    Eltze M; König H; Ullrich B; Grebe T
    Eur J Pharmacol; 2001 Mar; 415(2-3):265-76. PubMed ID: 11275009
    [TBL] [Abstract][Full Text] [Related]  

  • 43. 3H-yohimbine binding to guinea-pig kidney and calf cerebral cortex membranes: comparison with human platelets.
    Brodde OE; Eymer T; Arroyo J
    Arch Int Pharmacodyn Ther; 1983 Dec; 266(2):208-20. PubMed ID: 6320754
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of the binding affinity of CGP-12177A at recombinant rat alpha(1D)-adrenoceptors expressed in BHK-21 cell membranes and alpha(1)-adrenoceptors present in rat cerebral cortex membranes.
    Floreani M; Varani K; Quintieri L; Borea PA; Dorigo P
    Eur J Pharmacol; 2008 Aug; 590(1-3):303-9. PubMed ID: 18589413
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Affinity of different alpha 1-agonists and antagonists for the alpha 1-adrenoceptors of rabbit and rat liver membranes.
    Taddei C; Poggesi E; Leonardi A; Testa R
    Life Sci; 1993; 53(12):PL177-81. PubMed ID: 8103184
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Errors introduced in radioligand binding studies due to displaceable, cation dependent, [3H]prazosin binding to glass-fibre filters and glass surfaces.
    Veenstra DM; van Buuren KJ; Krielaart MJ; Nijkamp FP
    J Recept Res; 1993; 13(5):801-14. PubMed ID: 8463996
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Identification of alpha 1-adrenoceptor subtypes in the rat vas deferens: binding and functional studies.
    Ohmura T; Oshita M; Kigoshi S; Muramatsu I
    Br J Pharmacol; 1992 Nov; 107(3):697-704. PubMed ID: 1361871
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Interactions of the enantiomers of 3-O-methyldobutamine with alpha- and beta-adrenoceptors in vitro.
    Ruffolo RR; Messick K; Horng JS
    Naunyn Schmiedebergs Arch Pharmacol; 1985 May; 329(3):244-52. PubMed ID: 2991776
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Whether phenylephrine exerts inotropic effects through alpha- or beta-adrenoceptors depends upon the relative receptor populations.
    Chess-Williams RG; Williamson KL; Broadley KJ
    Fundam Clin Pharmacol; 1990; 4(1):25-37. PubMed ID: 2160415
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Affinity of the miotic drug, dapiprazole, at alpha 1-adrenoceptor subtypes A, B and D.
    Eltze M
    J Pharm Pharmacol; 1997 Nov; 49(11):1091-5. PubMed ID: 9401944
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Modulation of 5-hydroxytryptamine release by presynaptic inhibitory alpha 2-adrenoceptors in the human cerebral cortex.
    Raiteri M; Maura G; Folghera S; Cavazzani P; Andrioli GC; Schlicker E; Schalnus R; Göthert M
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Nov; 342(5):508-12. PubMed ID: 1982558
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Alpha-1 and alpha-2 adrenoceptor binding in cerebral cortex: role of disulfide and sulfhydryl groups.
    Reader TA; Brière R; Grondin L
    Neurochem Res; 1986 Jan; 11(1):9-27. PubMed ID: 2870441
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Heterogeneity of mammalian alpha 2-adrenoceptors delineated by [3H]yohimbine binding.
    Dickinson KE; McKernan RM; Miles CM; Leys KS; Sever PS
    Eur J Pharmacol; 1986 Jan; 120(3):285-93. PubMed ID: 3005004
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Rat pineal alpha 1-adrenoceptor subtypes: studies using radioligand binding and reverse transcription-polymerase chain reaction analysis.
    Sugden D; Anwar N; Klein DC
    Br J Pharmacol; 1996 Jul; 118(5):1246-52. PubMed ID: 8818350
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evidence for multiple [3H]prazosin binding sites in canine brain membranes.
    Mignot E; Bowersox SS; Maddaluno J; Dement W; Ciaranello R
    Brain Res; 1989 May; 486(1):56-66. PubMed ID: 2541871
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Characterization of the hepatic alpha 1B-adrenoceptors of rats, mice and hamsters.
    García-Sáinz JA; Casas-González P; Romero-Avila MT; González-Espinosa C
    Life Sci; 1994; 54(25):1995-2003. PubMed ID: 7911220
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In functional experiments, risperidone is selective, not for the B, but for the A subtype of alpha 1-adrenoceptors.
    Eltze M
    Eur J Pharmacol; 1996 Jan; 295(1):69-73. PubMed ID: 8925876
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Subtypes of alpha 1-adrenoceptors in hippocampus of pigs, guinea-pigs, calves and humans: regional differences.
    Hoyer D; Jones CR; Ford W; Palacios JM
    Eur J Pharmacol; 1990 Jan; 188(1):9-16. PubMed ID: 1968395
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The effects of electroconvulsive shock or imipramine on subtypes of alpha 1-adrenoceptors in the frontal cortex of the rat.
    Hayakawa H; Shimizu M; Yamawaki S
    Neuropharmacology; 1992 Sep; 31(9):955-60. PubMed ID: 1359445
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Characterization of specific binding of [125I]L-762,459, a selective alpha1A-adrenoceptor radioligand to rat and human tissues.
    O'Malley SS; Chen TB; Francis BE; Gibson RE; Burns HD; DiSalvo J; Bayne ML; Wetzel JM; Nagarathnam D; Marzabadi M; Gluchowski C; Chang RS
    Eur J Pharmacol; 1998 May; 348(2-3):287-95. PubMed ID: 9652345
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.